Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Anti-inflammatory Peptides market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Anti-inflammatory Peptidesmarket, defines the market attractiveness level of Anti-inflammatory Peptides market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Anti-inflammatory Peptides industry, describes the types of Anti-inflammatory Peptides market, the applications of major players and the market size, and deeply analyzes the current situation of the global Anti-inflammatory Peptides market and the development prospects and opportunities of Anti-inflammatory Peptides industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Anti-inflammatory Peptides market in Chapter 13.
By Player:
Rogne Bioscience
F4 Pharma
Novartis AG
Digna Biotech
Araim Pharmaceuticals, Inc
Abbvie Corporation
Mylan Pharmaceuticals
Merck Serono
By Type:
Cardiovascular Diseases
Gastrointestinal Diseases
Dermatological Diseases
Neurological Diseases
Otorhino Diseases & Ophthalmological
Respiratory Diseases & Pulmonary
Renal Diseases
Rheumatological & Autoimmune Diseases
Transplantation
By End-User:
Hospital Use
Clinic Use
Household
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Anti-inflammatory Peptides Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Anti-inflammatory Peptides Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Anti-inflammatory Peptides Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Anti-inflammatory Peptides Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Anti-inflammatory Peptides Market Analysis and Outlook to 2022
-
7.1 Global Anti-inflammatory Peptides Consumption (2017-2022)
-
7.2 United States Anti-inflammatory Peptides Consumption (2017-2022)
-
7.3 Europe Anti-inflammatory Peptides Consumption (2017-2022)
-
7.4 China Anti-inflammatory Peptides Consumption (2017-2022)
-
7.5 Japan Anti-inflammatory Peptides Consumption (2017-2022)
-
7.6 India Anti-inflammatory Peptides Consumption (2017-2022)
-
7.7 South Korea Anti-inflammatory Peptides Consumption (2017-2022)
8 Region and Country-wise Anti-inflammatory Peptides Market Analysis and Outlook to 2028
-
8.1 Global Anti-inflammatory Peptides Consumption Forecast (2022-2028)
-
8.2 United States Anti-inflammatory Peptides Consumption Forecast (2022-2028)
-
8.3 Europe Anti-inflammatory Peptides Consumption Forecast (2022-2028)
-
8.4 China Anti-inflammatory Peptides Consumption Forecast (2022-2028)
-
8.5 Japan Anti-inflammatory Peptides Consumption Forecast (2022-2028)
-
8.6 India Anti-inflammatory Peptides Consumption Forecast (2022-2028)
-
8.7 South Korea Anti-inflammatory Peptides Consumption Forecast (2022-2028)
9 Global Anti-inflammatory Peptides Market Outlook by Types and Applications to 2022
-
9.1 Global Anti-inflammatory Peptides Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Cardiovascular Diseases Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Gastrointestinal Diseases Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Dermatological Diseases Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Neurological Diseases Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Otorhino Diseases & Ophthalmological Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Respiratory Diseases & Pulmonary Consumption and Growth Rate (2017-2022)
-
9.1.7 Global Renal Diseases Consumption and Growth Rate (2017-2022)
-
9.1.8 Global Rheumatological & Autoimmune Diseases Consumption and Growth Rate (2017-2022)
-
9.1.9 Global Transplantation Consumption and Growth Rate (2017-2022)
-
9.2 Global Anti-inflammatory Peptides Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Use Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinic Use Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Household Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Other Consumption and Growth Rate (2017-2022)
10 Global Anti-inflammatory Peptides Market Outlook by Types and Applications to 2028
-
10.1 Global Anti-inflammatory Peptides Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Cardiovascular Diseases Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Gastrointestinal Diseases Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Dermatological Diseases Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Neurological Diseases Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Otorhino Diseases & Ophthalmological Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Respiratory Diseases & Pulmonary Consumption Forecast and Growth Rate (2022-2028)
-
10.1.7 Global Renal Diseases Consumption Forecast and Growth Rate (2022-2028)
-
10.1.8 Global Rheumatological & Autoimmune Diseases Consumption Forecast and Growth Rate (2022-2028)
-
10.1.9 Global Transplantation Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Anti-inflammatory Peptides Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Use Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinic Use Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Household Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Anti-inflammatory Peptides Import and Export Analysis (Top 5 Countries)
-
11.1 Global Anti-inflammatory Peptides Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Anti-inflammatory Peptides Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Anti-inflammatory Peptides Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Anti-inflammatory Peptides Market Competitive Analysis
-
14.1 Rogne Bioscience
-
14.1.1 Rogne Bioscience Company Details
-
14.1.2 Rogne Bioscience Anti-inflammatory Peptides Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Rogne Bioscience Anti-inflammatory Peptides Product and Service
-
14.2 F4 Pharma
-
14.2.1 F4 Pharma Company Details
-
14.2.2 F4 Pharma Anti-inflammatory Peptides Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 F4 Pharma Anti-inflammatory Peptides Product and Service
-
14.3 Novartis AG
-
14.3.1 Novartis AG Company Details
-
14.3.2 Novartis AG Anti-inflammatory Peptides Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Novartis AG Anti-inflammatory Peptides Product and Service
-
14.4 Digna Biotech
-
14.4.1 Digna Biotech Company Details
-
14.4.2 Digna Biotech Anti-inflammatory Peptides Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Digna Biotech Anti-inflammatory Peptides Product and Service
-
14.5 Araim Pharmaceuticals, Inc
-
14.5.1 Araim Pharmaceuticals, Inc Company Details
-
14.5.2 Araim Pharmaceuticals, Inc Anti-inflammatory Peptides Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Araim Pharmaceuticals, Inc Anti-inflammatory Peptides Product and Service
-
14.6 Abbvie Corporation
-
14.6.1 Abbvie Corporation Company Details
-
14.6.2 Abbvie Corporation Anti-inflammatory Peptides Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Abbvie Corporation Anti-inflammatory Peptides Product and Service
-
14.7 Mylan Pharmaceuticals
-
14.7.1 Mylan Pharmaceuticals Company Details
-
14.7.2 Mylan Pharmaceuticals Anti-inflammatory Peptides Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Mylan Pharmaceuticals Anti-inflammatory Peptides Product and Service
-
14.8 Merck Serono
-
14.8.1 Merck Serono Company Details
-
14.8.2 Merck Serono Anti-inflammatory Peptides Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Merck Serono Anti-inflammatory Peptides Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Anti-inflammatory Peptides
-
Figure Anti-inflammatory Peptides Picture
-
Table Global Anti-inflammatory Peptides Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Anti-inflammatory Peptides Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Anti-inflammatory Peptides Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Anti-inflammatory Peptides Consumption by Country (2017-2022)
-
Figure United States Anti-inflammatory Peptides Consumption and Growth Rate (2017-2022)
-
Table Europe Anti-inflammatory Peptides Consumption and Growth Rate (2017-2022)
-
Figure China Anti-inflammatory Peptides Consumption and Growth Rate (2017-2022)
-
Figure Japan Anti-inflammatory Peptides Consumption and Growth Rate (2017-2022)
-
Figure India Anti-inflammatory Peptides Consumption and Growth Rate (2017-2022)
-
Figure South Korea Anti-inflammatory Peptides Consumption and Growth Rate (2017-2022)
-
Figure Global Anti-inflammatory Peptides Consumption Forecast by Country (2022-2028)
-
Figure United States Anti-inflammatory Peptides Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Anti-inflammatory Peptides Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Anti-inflammatory Peptides Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Anti-inflammatory Peptides Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Anti-inflammatory Peptides Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Anti-inflammatory Peptides Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cardiovascular Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Gastrointestinal Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Dermatological Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Neurological Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Otorhino Diseases & Ophthalmological Consumption and Growth Rate (2017-2022)
-
Figure Global Respiratory Diseases & Pulmonary Consumption and Growth Rate (2017-2022)
-
Figure Global Renal Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Rheumatological & Autoimmune Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Transplantation Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Use Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Use Consumption and Growth Rate (2017-2022)
-
Figure Global Household Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Cardiovascular Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Gastrointestinal Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Dermatological Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Neurological Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Otorhino Diseases & Ophthalmological Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Respiratory Diseases & Pulmonary Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Renal Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Rheumatological & Autoimmune Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Transplantation Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Use Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Use Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Household Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Anti-inflammatory Peptides Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Anti-inflammatory Peptides Export by Region (Top 5 Countries) (2017-2028)
-
Table Rogne Bioscience (Foundation Year, Company Profile and etc.)
-
Table Rogne Bioscience Anti-inflammatory Peptides Sales, Price, Value and Gross Profit (2017-2022)
-
Table Rogne Bioscience Anti-inflammatory Peptides Product and Service
-
Table F4 Pharma (Foundation Year, Company Profile and etc.)
-
Table F4 Pharma Anti-inflammatory Peptides Sales, Price, Value and Gross Profit (2017-2022)
-
Table F4 Pharma Anti-inflammatory Peptides Product and Service
-
Table Novartis AG (Foundation Year, Company Profile and etc.)
-
Table Novartis AG Anti-inflammatory Peptides Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis AG Anti-inflammatory Peptides Product and Service
-
Table Digna Biotech (Foundation Year, Company Profile and etc.)
-
Table Digna Biotech Anti-inflammatory Peptides Sales, Price, Value and Gross Profit (2017-2022)
-
Table Digna Biotech Anti-inflammatory Peptides Product and Service
-
Table Araim Pharmaceuticals, Inc (Foundation Year, Company Profile and etc.)
-
Table Araim Pharmaceuticals, Inc Anti-inflammatory Peptides Sales, Price, Value and Gross Profit (2017-2022)
-
Table Araim Pharmaceuticals, Inc Anti-inflammatory Peptides Product and Service
-
Table Abbvie Corporation (Foundation Year, Company Profile and etc.)
-
Table Abbvie Corporation Anti-inflammatory Peptides Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbvie Corporation Anti-inflammatory Peptides Product and Service
-
Table Mylan Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Mylan Pharmaceuticals Anti-inflammatory Peptides Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mylan Pharmaceuticals Anti-inflammatory Peptides Product and Service
-
Table Merck Serono (Foundation Year, Company Profile and etc.)
-
Table Merck Serono Anti-inflammatory Peptides Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Serono Anti-inflammatory Peptides Product and Service
-
